N

    NewGenIvf Group Limited Class A Ordinary Shares (NIVF)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.45
    +0.03 (+6.64%)

    Market Cap: $2.70M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Mar 26
    		$N/AN/AN/ABeat-
    Sep 25
    		$0.73$0.00N/ABeat+100.0%
    Mar 25
    		$0.00$0.00N/ABeat-100.0%
    Dec 24
    		$-855.66N/AN/ABeat-130.1%
    Sep 24
    		$-0.04N/AN/ABeat-500.0%
    Dec 23
    		$-46153.06N/AN/ABeat-57691419.6%
    Sep 23
    		$4217.09N/AN/ABeat+21085354.5%
    Jun 23
    		$2838.50N/AN/ABeat+17396.0%
    Mar 23
    		$0.01N/AN/ABeat+150.0%
    Dec 22
    		$0.08N/AN/ABeat-
    Sep 22
    		$0.02N/AN/ABeat-
    Jun 22
    		$-16.41N/AN/ABeat-
    Mar 22
    		$-0.02N/AN/ABeat-
    Dec 21
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.00EV/EBITDA0.66x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin209.00%Operating Margin-349.10%
    ROE79.40%ROIC33.39%
    Financial Health
    Debt/Equity0.16xInterest Coverage16.78x
    Current Ratio3.12xQuick Ratio2.98x
    Trading Statistics
    Beta-0.00Avg Volume676.65K
    52-Week High$513.0052-Week Low$0.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.51
    SMA 20$0.55
    SMA 50$1.03
    SMA 200$13.28
    EMA 10$0.50
    EMA 20$0.61
    EMA 50$1.33
    EMA 200$644.46

    MACD

    Line: -0.17Signal: -0.20Hist: 0.03

    ADX

    ADX: 19.7+DI: 11.9-DI: 16.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.52

    Bollinger Bands

    Upper Band$0.67
    Lower Band$0.43
    %B Position4389%(Upper)
    Band Width0.09

    RSI (14-Day)

    Oversold
    29.9

    Momentum Oscillators

    Stoch %K11.3
    Stoch %D12.5
    Williams %R-79.4
    ROC (10d)-26.1%
    Momentum-0.16
    CCI (20d)-154.9
    MFI (14d)47.5

    Volatility Measures

    ATR (14d)$0.16(36.0%)
    StdDev (20d)0.06
    Hist Vol129.4%(High)

    Volume Flow

    VWAP$0.44
    OBV17.0M
    AD Line5922.6B
    CMF (20d)0.003

    Volume Metrics

    Avg Vol (20d)693.2K
    Vol Ratio0.6x
    VWMA (20d)$0.56

    Pivot Points

    R3$0.48
    R2$0.46
    R1$0.44
    Pivot Point$0.42
    S1$0.40
    S2$0.38
    S3$0.37

    Advanced Oscillators

    TSI-44.72
    Ultimate Osc40.6
    KST-460.12

    Financial Data

    QuarterDec 2025Sep 2025Mar 2025Dec 2024Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$1.42M$1.28M$1.27M$1.27M$1.47M$1.52MN/AN/AN/AN/AN/AN/A
    Cost of Revenue$900,529$1.16M$734,477$734,477$824,034$1.32MN/AN/AN/AN/AN/AN/A
    Gross Profit$524,025$118,017$539,135$539,135$648,827$196,825N/AN/AN/AN/AN/AN/A
    Operating Expenses$5.50M$2.63M$1.63M$2.36M$432,516$1.27M$1.27M$377,717$367,000$510,547$115,638$106,551
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$4.80M$2.44M$1.61M$1.63M$296,972$0$0$0$0$0$0$0
    Operating Income$-4,973,594$-2,512,491$-1,089,120$-1,089,120$216,311$196,825$-1,266,340$-377,717$-367,000$-510,547$-115,638$-106,551
    Interest Income$248$409$0$4,554$10,522$0$0$0$0$0$0$0
    Interest Expense$442,840$48,094$421,105$421,105$247,911$25,257$0$0$0$0$0$0
    Income Before Tax$-7,717,290$16.75M$-543,000$-542,684$-30,342$295,584$-955,489$127,021$85,497$52,120$474,362$208,323
    Income Tax Expense$0$0$-487,000$0$0$-83,742$0$0$0$0$0$0
    Net Income$-7,668,922$16.82M$-108,000$-108,243$-19,857$335,625$-955,489$127,021$85,497$52,120$474,362$208,323
    EBITDA$-7,274,450$16.80M$58,327N/A$226,870$363,775$-1,266,340$127,021$85,496$52,120$474,362$208,323
    EBITN/AN/A$-121,577N/A$217,571$196,825$-1,266,340$-377,717$-367,000$-510,547$-115,638$-106,551
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NIVF

    News

    NewGenIVF issues shares to buy 3% stake in K25.ai

    NewGenIVF has issued shares through strategic share purchase agreements to acquire a 3% equity interest in K25.ai, increasing its total outstanding Class A shares to 5,919,948. This transaction has led to the market value of NewGenIVF's listed securities reaching US$5.03 million, based on the closing price of $0.85 on July 30, 2026. The information was initially published by NewGenIVF Group Ltd. via EDGAR.

    Bitget•8/1/26•
    Neutral

    12 Health Care Stocks Moving In Friday's After-Market Session

    This article lists 12 healthcare stocks that experienced significant price movements during Friday's after-market session. It highlights both gainers, such as Universe Pharmaceuticals and BGM Group, and losers, including NewGenIvf Group and Profusa, providing their percentage change and market capitalization. The movements range from a 91.1% increase for Universe Pharmaceuticals to an 18.1% decrease for NewGenIvf Group.

    Sahm•7/31/26•
    Bearish

    NewGenIVF Group (NIVF) lifts share count with K25.ai stake move

    NewGenIVF Group Limited (NIVF) announced an updated total of 5,919,948 outstanding Class A shares. This change is due to share issuances related to strategic agreements to acquire a 3% equity interest in K25.ai. Based on the closing share price of $0.85 on July 30, 2026, the company's Market Value of Listed Securities is now US$5,031,956.

    Stock Titan•7/31/26•
    Neutral

    NewGen’s K25.ai Stake Awaits Completion; ~$8.5M Unrealized Gain Expected

    NewGen (Nasdaq: NIVF) announced that its 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai's recent Series A funding round which implied a US$200 million valuation. This represents an expected unrealized gain of about US$8.5 million for NewGen, pending the completion of share purchase agreements. The company reported a net profit of US$9.9 million for fiscal year 2025 and net assets of US$25.98 million, with the K25.ai appreciation further strengthening its financial position in 2026.

    Stock Titan•7/31/26•
    Bullish

    NewGenIvf Group (NasdaqCM:NIVF) Stock Price

    NewGenIvf Group Limited (NIVF), an assisted reproductive service provider with a US$790.3k market cap, recently saw a significant stock price decline. The company provides fertility treatments across several Asian countries and has a moderate risk profile. Recent news includes the cancellation of a reverse merger with SAXA, Inc., the appointment of Joshua Chu as Senior Counsel for their tokenization strategy, and an announced $2 million share buyback program.

    Simply Wall Street•7/28/26•
    Bearish

    Frequently Asked Questions About NIVF

    Does NIVF pay dividends?
    NewGenIvf Group Limited Class A Ordinary Shares (NIVF) does not currently pay a regular dividend.
    What is NIVF's market cap?
    NewGenIvf Group Limited Class A Ordinary Shares (NIVF) has a market capitalization of $2.70M with a current stock price of $0.45.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In